Literature DB >> 26096509

Valproic acid hypersensitivity and desensitization.

Ori Toker1, Yuval Tal2, Liran Horev3, Dorit Shmoeli4, Tal Gilboa5.   

Abstract

Rash, a hypersensitivity reaction, is a common cause of withdrawal from an effective antiepileptic drug (AED) in patients with epilepsy. We present a case of successful desensitization to valproic acid in a 12-year-old male with childhood absence epilepsy and a hypersensitivity reaction, whose epilepsy did not respond to other AEDs. Desensitization is a practical therapeutic solution for patients who develop a non-life-threatening hypersensitivity reaction to an AED for which there may be no substitute.
© 2015 Mac Keith Press.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26096509     DOI: 10.1111/dmcn.12835

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  3 in total

1.  Desensitization to Oxcarbazepine: Long-Term Efficacy and Tolerability.

Authors:  Jiwon Lee; Eu Gene Park; Munhyang Lee; Jeehun Lee
Journal:  J Clin Neurol       Date:  2016-10-07       Impact factor: 3.077

2.  A new rapid titration protocol for lamotrigine that reduces the risk of skin rash.

Authors:  Yoonhyuk Jang; Jangsup Moon; Narae Kim; Tae-Joon Kim; Jin-Sun Jun; Yong-Won Shin; Hyeyeon Chang; Hye-Ryun Kang; Soon-Tae Lee; Keun-Hwa Jung; Kyung-Il Park; Ki-Young Jung; Kon Chu; Sang Kun Lee
Journal:  Epilepsia Open       Date:  2021-05-07

3.  Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy.

Authors:  Lingyan Yu; Zhiliang Wang; Zhenwei Yu; Jianhua Feng; Haibin Dai
Journal:  Ann Clin Transl Neurol       Date:  2021-06-28       Impact factor: 4.511

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.